MIGS: Micro Incisional Glaucoma Surgery
Glaucoma is a sight-threatening disease that affects millions of people world wide. Simply, the eye fluid is causing a build-up of pressure in the eye(IOP). Glaucoma is the second leading cause of blindness in the world (Cataract is #1). 3 million Americans have glaucoma, but half of them do not know it. The leading risk factors are age, family history, and diabetes. African American patients are at an increased risk of developing glaucoma, and losing vision to it, than Caucasian patients, and it can strike them earlier. it is important to see an eye doctor regularly and get screened for glaucoma progression. Early diagnosis and treatment is the key to preserving visual function for your lifetime. Dr. Rubinchik uses advanced diagnostic equipment to identify glaucoma and track its progression. Borderline patients are followed until progression is noted. Those with progression are managed with eye drops to lower the IOP. If the IOP is difficult to control with medication, options to manage the IOP through surgical means are discussed.
During cataract surgery, Dr. Rubinchik can insert the I stent, a device which allows increased drainage of the eye fluid from the eye. EndoCycloPhotocoagulation (ECP) is also an option. During cataract surgery, a probe is inserted into the eye, and Ciliary processes (nodes in the eye that create Aqueous Humor) are painlessly inactivated to reduce production of the fluid that creates eye pressure AND reduce a patients reliance on eye drops.